QIAGEN NV (QGEN)

40.56
NYSE : Health Technology
Prev Close 37.28
Day Low/High 37.15 / 41.00
52 Wk Low/High 25.04 / 41.55
Avg Volume 1.85M
Exchange NYSE
Shares Outstanding 226.49M
Market Cap 8.44B
EPS 0.80
P/E Ratio 45.46
Div & Yield N.A. (N.A)

Latest News

Qiagen Jumps on Report Thermo Fisher Is Considering a Bid

Qiagen Jumps on Report Thermo Fisher Is Considering a Bid

Qiagen rises following a report that says Thermo Fisher Scientific is considering a purchase of the Dutch molecular-testing company.

ROSEN, A LEADING GLOBAL LAW FIRM, Continues To Investigate Securities Claims Against QIAGEN N.V. - QGEN

ROSEN, A LEADING GLOBAL LAW FIRM, Continues To Investigate Securities Claims Against QIAGEN N.V. - QGEN

Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Qiagen N.

QIAGEN Launches Novel NGS Workflow For Simultaneous DNA And RNA Analysis For Use In Cancer Profiling At 2019 AMP Annual Meeting

QIAGEN Launches Novel NGS Workflow For Simultaneous DNA And RNA Analysis For Use In Cancer Profiling At 2019 AMP Annual Meeting

QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced an expansion of its QIAseq NGS portfolio to offer a one-day workflow for simultaneous preparation of DNA and RNA libraries using next-generation sequencing (NGS) technologies.

QIAGEN Expands Portfolio Of Immuno-Oncology Assets For Future Companion Diagnostics And Biomarkers

QIAGEN Expands Portfolio Of Immuno-Oncology Assets For Future Companion Diagnostics And Biomarkers

QIAGEN (NYSE:QGEN; Frankfurt Prime Standard:QIA) today announced a series of agreements that expand its immuno-oncology assets for future commercialization of novel companion diagnostics for precision medicine in immuno-oncology, in particular based on...

QIAGEN (QGEN) Alert: Johnson Fistel Launches Investigation Into QIAGEN N.V.; Investors Encouraged To Contact Firm

QIAGEN (QGEN) Alert: Johnson Fistel Launches Investigation Into QIAGEN N.V.; Investors Encouraged To Contact Firm

SAN DIEGO, Oct. 22, 2019 /PRNewswire/ -- Shareholder Rights Law Firm Johnson Fistel, LLP, is investigating potential claims against QIAGEN N.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ADT, CMPR, HVBC, SPAR Downgrades: AMTD, ESQ, JAZZ, PMBC, QD, QGEN, SCHN, SLB, TDW, WUBA Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

QIAGEN Launches New QIAseq FastSelect Solutions To Accelerate RNA-seq

QIAGEN Launches New QIAseq FastSelect Solutions To Accelerate RNA-seq

QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of innovative new technologies for faster, simpler library preparation for next-generation sequencing (NGS) in the growing field of RNA research.

QGEN LOSSES ALERT: Bernstein Liebhard LLP Reminds Investors Of Its Investigation Of Qiagen N.V.

QGEN LOSSES ALERT: Bernstein Liebhard LLP Reminds Investors Of Its Investigation Of Qiagen N.V.

NEW YORK, Oct. 9, 2019 /PRNewswire/ -- Bernstein Liebhard, a nationally acclaimed investor rights law firm, is investigating potential securities fraud claims on behalf of shareholders of Qiagen N.

QGEN SHAREHOLDER ALERT: Hagens Berman Notifies Investors In Qiagen (QGEN) Of An Investigation Involving Possible Securities Law Violations

QGEN SHAREHOLDER ALERT: Hagens Berman Notifies Investors In Qiagen (QGEN) Of An Investigation Involving Possible Securities Law Violations

Class-action law firm urges QGEN investors who have suffered significant losses to learn their shareholder rights

EQUITY ALERT: ROSEN, A TOP RANKED LAW FIRM, Announces Investigation Of Securities Claims Against QIAGEN N.V. - QGEN

EQUITY ALERT: ROSEN, A TOP RANKED LAW FIRM, Announces Investigation Of Securities Claims Against QIAGEN N.V. - QGEN

Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of Qiagen N.

Jim Cramer: A Terrible Moment for the Stock Market

Jim Cramer: A Terrible Moment for the Stock Market

If your goal is to ratchet up trade tension? There couldn't been a better moment, hence one of the worst moments for the stock market since the trade battle began.

SHAREHOLDER ALERT: Gardy & Notis, LLP Investigation Of Shareholder Claims Against Qiagen (NYSE: QGEN)

SHAREHOLDER ALERT: Gardy & Notis, LLP Investigation Of Shareholder Claims Against Qiagen (NYSE: QGEN)

NEW YORK, Oct. 8, 2019 /PRNewswire/ -- The law firm Gardy & Notis, LLP is investigating potential claims against Qiagen N.

Qiagen Tumbles on Sales Warning, CEO Departure

Qiagen Tumbles on Sales Warning, CEO Departure

Shares of Qiagen slide after the company warns its third-quarter sales will be lower than expected and that its CEO is resigning.

QIAGEN Announces CEO Leadership Transition

QIAGEN Announces CEO Leadership Transition

QIAGEN N.V.

QIAGEN And Illumina Partner To Deliver Sequencing-Based In-Vitro Diagnostic (IVD) Tests

QIAGEN And Illumina Partner To Deliver Sequencing-Based In-Vitro Diagnostic (IVD) Tests

Illumina, Inc. (NASDAQ: ILMN) and QIAGEN N.

Illumina And QIAGEN Partner To Deliver Sequencing-Based In-Vitro Diagnostic (IVD) Tests

Illumina And QIAGEN Partner To Deliver Sequencing-Based In-Vitro Diagnostic (IVD) Tests

Illumina, Inc. (NASDAQ: ILMN) and QIAGEN N.

QIAGEN Launches Enhanced GeneGlobe Design & Analysis Hub, Combining Curated Knowledge, Content-based Assays And Analyses For Life Science Research

QIAGEN Launches Enhanced GeneGlobe Design & Analysis Hub, Combining Curated Knowledge, Content-based Assays And Analyses For Life Science Research

QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of its newly enhanced GeneGlobe Design & Analysis Hub, bringing next-level experiment planning, execution and follow-up to life science researchers.

QIAGEN Announces Change In Global Sales Structure

QIAGEN Announces Change In Global Sales Structure

QIAGEN N.V.

QIAGEN's New QIAstat-Dx Gastrointestinal Panel Demonstrates Excellent Performance In Multicenter Clinical Study In Europe

QIAGEN's New QIAstat-Dx Gastrointestinal Panel Demonstrates Excellent Performance In Multicenter Clinical Study In Europe

QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the publication of a multicenter clinical study demonstrating the accuracy of its QIAstat-Dx syndromic testing solution for diagnosing the causes of acute gastroenteritis.

QIAGEN Clinical Insight Surpasses 1 Million Patient Test Cases Analyzed And Interpreted

QIAGEN Clinical Insight Surpasses 1 Million Patient Test Cases Analyzed And Interpreted

QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that QIAGEN Clinical Insight (QCI®), its clinical decision support platform for interpretation and reporting of variants derived from analysis of next-generation sequencing (NGS) data, has...

QIAGEN And McKesson Agree To Distribute QIAstat-Dx Syndromic Testing Solution To Smaller Hospitals And Other Select Segments In The United States

QIAGEN And McKesson Agree To Distribute QIAstat-Dx Syndromic Testing Solution To Smaller Hospitals And Other Select Segments In The United States

QIAGEN (NYSE:QGEN; Frankfurt Prime Standard: QIA) today announced an agreement for McKesson Medical-Surgical Inc.

TheStreet Quant Rating: C- (Hold)